ESR1 and breast cancer: MHO7 showed a robust effect on non-TNBC cell lines, such as MCF-7, T47D and ZR-75-1 cells, with IC50 values of 1.24~7.14 μM, and it was identified as a potent estrogen receptor (ERα) degrader in breast cancer 26.